The Organic & Non-GMO Report Newsletter
Jurassic Park coming to the Arctic? Scientist aims to “de-extinct” wooly mammoth as solution to climate change
In what would seem to be a “Colossal” publicity stunt or a headline from The Onion, a tech entrepreneur and Harvard geneticist have hatched a plan to genetically engineer Asian elephants to resemble long-extinct wooly mammoths as a way to slow global warming. What could possibly go wrong? Entrepreneur Ben Lamm and geneticist George Church, […]
Read MoreLayn expands non-GMO natural extract portfolio
In response to demand for cleaner, transparent products, Layn Natural Ingredients recently announced it has expanded its line of Non-GMO Project Verified botanical extracts for use in food and beverage applications, including pet food and treats. Previous offerings from Layn, in its Non-GMO Project Verified line, include plant-based sweeteners such as stevia, monk fruit, sweet […]
Read MoreBrazil’s millers oppose GMO wheat imports
Brazil’s flour millers are threatening to stop buying wheat from Argentina if Brazil approves genetically modified wheat imports from its neighbor. According to the Brazilian Wheat Industry Association (Abitrigo), local millers are opposed to processing GMO wheat from Argentina or any other country. Rubens Barbosa, head of Abitrigo, told Reuters: “There is no country in […]
Read More7th annual Organic & Non-GMO Forum
The 7th annual Organic & Non-GMO Forum will take place in-person, December 1-2 at the Hyatt Regency in Minneapolis and focus on the opportunities, innovations and challenges in the burgeoning plant-based sector. The ONG Forum brings together producers, processors, manufacturers, buyers, investors, and others in the supply chain to discuss the challenges, opportunities, and constant […]
Read More$200M facility in Ohio will farm AquaBounty’s genetically engineered salmon
By 2023, 10,000 metric tons of genetically modified salmon will come to market each year from a land-based Ohio fish farm being built by AquaBounty. The developer of the first GM animal approved for human consumption in the U.S. is investing $200 million in a 479,000-square-foot facility, expanding by eight times the capacity of its […]
Read More